In vitro uptake and release of natamycin Dex -b- PLA nanoparticles from model contact lens materials

Journal of Biomaterials Science, Polymer Edition

Volumn 25, Issue 1, 2014, Pages 18-31

  Phan, Chau Minh ^a   Subbaraman, Lakshman ^a   Liu, Shengyan ^b   Gu, Frank ^b   Jones, Lyndon ^a  

^a UNIVERSITY OF WATERLOO   (Canada)

^b UNIVERSITY OF WATERLOO   (Canada)

Author keywords

antifungal; contact lens; drug delivery; nanoparticle; natamycin; silicone hydrogel

Indexed keywords

ANTI-FUNGAL; CONTACT LENS MATERIAL; HYDROXYETHYL METHACRYLATE; N ,N-DIMETHYLACRYLAMIDE; NATAMYCIN; POLY (D ,L-LACTIDE); SILICONE HYDROGELS; UV-VISIBLE SPECTROPHOTOMETRY;

CONTACT LENSES; DEIONIZED WATER; DRUG DELIVERY; GELS; NANOPARTICLES; ORGANIC POLYMERS; PHEMA; SILICONES;

MATERIALS;

[TRIS(TRIMETHYLSILOXY)SILYL]PROPYL METHACRYLATE; DEXTRAN; DIMETHYL SULFOXIDE; ETHYLENE GLYCOL DIMETHACRYLATE; N,N DIMETHYLACRYLAMIDE; NANOPARTICLE; NATAMYCIN; POLYLACTIDE; POLYMACON; POLYMER; UNCLASSIFIED DRUG; WATER;

ARTICLE; CHEMICAL COMPOSITION; CONTACT LENS; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG UPTAKE; IN VITRO STUDY; NANOENCAPSULATION; PARTICLE SIZE; PRIORITY JOURNAL; ULTRAVIOLET SPECTROPHOTOMETRY; WATER CONTENT;

ANTIFUNGAL AGENTS; CONTACT LENSES; DEXTRANS; DRUG CARRIERS; HYDROGELS; NANOPARTICLES; NATAMYCIN; POLYESTERS; SILICONES;

EID: 84889878985     PISSN: 09205063     EISSN: 15685624     Source Type: Journal    
DOI: 10.1080/09205063.2013.830914     Document Type: Article

References (58)

1. Whitcher JP, Srinivasan M, Upadhyay MP. Corneal blindness: a global perspective. Bull. World Health Organ. 2001;79:214-221. (Pubitemid 32246479)
2. Thomas PA. Current perspectives on ophthalmic mycoses. Clin. Microbiol. Rev. 2003;16:730-797. (Pubitemid 37296558)
3. Bharathi MJ, Ramakrishnan R, Vasu S, Meenakshi R, Palaniappan R. Epidemiological characteristics and laboratory diagnosis of fungal keratitis: a three-year study. Indian J. Ophthalmol. 2003;51:315-321. (Pubitemid 38082261)
4. Leck A, Thomas P, Hagan M, Kaliamurthy J, Ackuaku E, John M, Newman M, Codjoe F, Opintan J, Kalavathy C. Aetiology of suppurative corneal ulcers in Ghana and south India, and epidemiology of fungal keratitis. Br. J. Ophthalmol. 2002;86:1211-1215. (Pubitemid 35238594)
5. Bharathi MJ, Ramakrishnan R, Shivakumar C, Meenakshi R, Lionalraj D. Etiology and antibacterial susceptibility pattern of community-acquired bacterial ocular infections in a tertiary eye care hospital in south India. Indian J. Ophthalmol. 2010;58:497-507.
6. Bandyopadhyay S, Das D, Mondal KK, Ghanta AK, Purkrit SK, Bhasrar R. Epidemiology and laboratory diagnosis of fungal corneal ulcer in the Sundarban Region of West Bengal, eastern India. Nepal J. Ophthalmol. 2012;4:29-36.
7. Katiyar R, Deorukhkar S, Saini S. Epidemiological features and laboratory results of bacterial and fungal keratitis: a five-year study at a rural tertiary-care hospital in western Maharashtra, India. Singapore Med. J. 2012;53:264-267.
8. Xuguang S, Zhixin W, Zhiqun W, Shiyun L, Ran L. Ocular fungal isolates and antifungal susceptibility in northern China. Am. J. Ophthalmol. 2007;143:131-133.
9. Sun XG, Zhang Y, Li R, Wang ZQ, Luo SY, Jin XY, Zhang WH. Etiological analysis on ocular fungal infection in the period of 1989-2000. Chin. Med. J. (Engl). 2004;117: 598-600. (Pubitemid 38579084)
10. Asbell P, Stenson S. Ulcerative keratitis: survey of 30 years' laboratory experience. Arch. Ophthalmol. 1982;100:77-80. (Pubitemid 12203060)
11. FlorCruz NV, Peczon IV, Evans Jr. Medical interventions for fungal keratitis. Cochrane Database Syst. Rev. 2012;2:CD004241.
12. Luisa HL. Therapeutic contact lens-related bilateral fungal keratitis. Eye Contact Lens. 2002;28:149-150.
13. Choi DM, Goldstein MH, Salierno A, Driebe WT. Fungal keratitis in a daily disposable soft contact lens wearer. Eye Contact Lens. 2001;27:111-112. (Pubitemid 32423390)
14. Le Liboux M, Ibara S, Quinio D, Moalic E. Fungal keratitis in a daily disposable soft contact lens wearer. J. Français D'ophtalmologie. 2004;27:401-403. (Pubitemid 38595898)
15. Elder BL, Bullock JD, Warwar RE, Khamis HJ, Khalaf SZ. Pan-antimicrobial failure of alexidine as a contact lens disinfectant when heated in Bausch & Lomb plastic containers: implications for the worldwide Fusarium keratitis epidemic of 2004 to 2006. Eye Contact Lens. 2012;38:222-226.
16. Yildiz EH, Abdalla YF, Elsahn AF, Rapuano CJ, Hammersmith KM, Laibson PR, Cohen EJ. Update on fungal keratitis from 1999 to 2008. Cornea. 2010;29:1406-1411.
17. Bullock JD, Elder BL, Khamis HJ, Warwar RE. Effects of time, temperature, and storage container on the growth of Fusarium species: implications for the worldwide Fusarium keratitis epidemic of 2004-2006. Arch. Ophthalmol. 2011;129:133-136.
18. O'Day DM. Selection of appropriate antifungal therapy. Cornea. 1987;6:238-245. (Pubitemid 18005950)
19. Loh AR, Hong K, Lee S, Mannis M, Acharya NR. Practice patterns in the management of fungal corneal ulcers. Cornea. 2009;28:856-859.
20. Kaur IP, Rana C, Singh H. Development of effective ocular preparations of antifungal agents. J. Ocul. Pharmacol. 2008;24:481-494.
21. Le Bourlais C, Acar L, Zia H, Sado PA, Needham T, Leverge R. Ophthalmic drug delivery systems-recent advances. Prog. Retin. Eye Res. 1998;17:33-58. (Pubitemid 28040752)
22. Yolton DP. Anti infective drugs. In: Bartlett JD, Jaanus SD, editors. Clinical ocular pharmacology. Woburn (MA): Butterworth-Heineman; 2001. p. 219-264.
23. Lim L, Tan D, Chan WK. Therapeutic use of Bausch & Lomb PureVision contact lenses. CLAO J. 2001;27:179-185. (Pubitemid 33032810)
24. Arora R, Jain S, Monga S, Narayanan R, Raina UK, Mehta DK. Efficacy of continuous wear PureVision contact lenses for therapeutic use. Cont. Lens Anterior Eye. 2004;27:39-43. (Pubitemid 38240369)
25. Foulks G, Harvey T, Raj C. Therapeutic contact lenses: the role of high-Dk lenses. Ophthalmol. Clin. North Am. 2003;16:455-461. (Pubitemid 37193806)
26. Gulsen D, Chauhan A. Ophthalmic drug delivery through contact lenses. Invest. Ophthalmol. Vis. Sci. 2004;45:2342-2347. (Pubitemid 38902607)
27. Phan CM, Subbaraman LN. In vitro uptake and release kinetics of natamycin from conventional and silicone hydrogel contact lens materials. Eye Contact Lens. 2012;39:162-168.
28. Gaudana R, Jwala J, Boddu SHS, Mitra AK. Recent perspectives in ocular drug delivery. Pharm. Res. 2009;26:1197-1216.
29. Budai L, Hajdú M, Budai M, Gróf P, Béni S, Noszál B, Klebovich I, Antal I. Gels and liposomes in optimized ocular drug delivery: studies on ciprofloxacin formulations. Int. J. Pharm. 2007;343:34-40. (Pubitemid 47334864)
30. Li C-C, Abrahamson M, Kapoor Y, Chauhan A. Timolol transport from microemulsions trapped in HEMA gels. J. Colloid Interface Sci. 2007;315:297-306. (Pubitemid 47410011)
31. Kassem M, Abdel Rahman A, Ghorab M, Ahmed M, Khalil R. Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs. Int. J. Pharm. 2007;340:126-133. (Pubitemid 47043351)
32. Sahoo SK, Dilnawaz F, Krishnakumar S. Nanotechnology in ocular drug delivery. Drug Discov. Today. 2008;13:144-151.
33. Gref R, Minamitake Y, Peracchia MT, Trubetskoy V, Torchilin V, Langer R. Biodegradable long-circulating polymeric nanospheres. Sci. Am. 1994;263:1600-1603. (Pubitemid 24128361)
34. Gaucher G, Marchessault RH, Leroux JC. Polyester-based micelles and nanoparticles for the parenteral delivery of taxanes. J. Controlled Release. 2010;143:2-12.
35. Karnik R, Gu F, Basto P, Cannizzaro C, Dean L, Kyei-Manu W, Langer R, Farokhzad OC. Microfluidic platform for controlled synthesis of polymeric nanoparticles. Nano Lett. 2008;8:2906-2912.
36. Snyder C. A primer on contact lens materials. Contact Lens Spectr. 2004;19:34-39.
37. Green JA, Phillips KS, Hitchins VM, Lucas AD, Shoff ME, Hutter JC, Rorer EM, Eydelman MB. Material properties that predict preservative uptake for silicone hydrogel contact lenses. Eye Contact Lens. 2012;38:350-357.
38. Verma MS, Liu SY, Chen YY, Meerasa A, Gu FX. Size-tunable nanoparticles composed of dextran-b-poly(D,L-lactide) for drug delivery applications. Nano Res. 2012;5:49-61.
39. Kim SW, Bae YH, Okano T. Hydrogels: swelling, drug loading, and release. Pharm. Res. 1992;9:283-290.
40. Ciolino JB, Hudson SP, Mobbs AN, Hoare TR, Iwata NG, Fink GR, Kohane DS. A prototype antifungal contact lens. Invest. Ophthalmol. Vis. Sci. 2011;52:6286-6291.
41. Dekker J, Ark P. Protection of antibiotic pimaricin from oxidation and ultraviolet light by chlorophyllin and other compounds. Antibiot. Chemother. 1959;9:327-332.
42. Koontz JL, Marcy JE, Barbeau WE, Duncan SE. Stability of natamycin and its cyclodextrin inclusion complexes in aqueous solution. J. Agric. Food Chem. 2003;51:7111-7114.
43. van Beek M, Weeks A, Jones L, Sheardown H. Immobilized hyaluronic acid containing model silicone hydrogels reduce protein adsorption. J. Biomater. Sci., Polym. Ed. 2008;19:1425-1436.
44. Kim J, Conway A, Chauhan A. Extended delivery of ophthalmic drugs by silicone hydrogel contact lenses. Biomaterials. 2008;29:2259-2269.
45. Xu J, Li X, Sun F, Cao P. PVA hydrogels containing β-cyclodextrin for enhanced loading and sustained release of ocular therapeutics. J. Biomater. Sci., Polym. Ed. 2010;21:1023-1038.
46. Karlgard C, Wong N, Jones L, Moresoli C. In vitro uptake and release studies of ocular pharmaceutical agents by silicon-containing and p-HEMA hydrogel contact lens materials. Int. J. Pharm. 2003;257:141-151. (Pubitemid 36507040)
47. Peng CC, Kim J, Chauhan A. Extended delivery of hydrophilic drugs from silicone-hydrogel contact lenses containing vitamin E diffusion barriers. Biomaterials. 2010;31:4032-4047.
48. Brazel CS, Peppas NA. Modeling of drug release from swellable polymers. Eur. J. Pharm. Biopharm. 2000;49:47-58. (Pubitemid 30009946)
49. Chrai SS, Makoid MC, Eriksen SP, Robinson Jr. Drop size and initial dosing frequency problems of topically applied ophthalmic drugs. J. Pharm. Sci. 1974;63:333-338.
50. Friedlaender MH, Breshears D, Amoozgar B, Sheardown H, Senchyna M. The dilution of benzalkonium chloride (BAK) in the tear film. Adv. Ther. 2006;23:835-841. (Pubitemid 46341041)
51. Shell JW. Pharmacokinetics of topically applied ophthalmic drugs. Surv. Ophthalmol. 1982;26:207-218. (Pubitemid 12188346)
52. Ghate D, Edelhauser HF. Barriers to glaucoma drug delivery. J. Glaucoma. 2008;17:147-156. (Pubitemid 351412405)
53. Le Bourlais C, Acar L, Zia H, Sado PA, Needham T, Leverge R. Ophthalmic drug delivery systems - recent advances. Prog. Retin. Eye Res. 1998;17:33-58. (Pubitemid 28040752)
54. Paugh JR, Stapleton F, Keay L, Ho A. Tear exchange under hydrogel contact lenses: methodological considerations. Invest. Ophthalmol. Vis. Sci. 2001;42:2813-2820. (Pubitemid 33035277)
55. Lin MC, Soliman GN, Lim VA, Giese ML, Wofford LE, Marmo C, Radke C, Polse KA. Scalloped channels enhance tear mixing under hydrogel contact lenses. Optom. Vis. Sci. 2006;83:874-878. (Pubitemid 44973499)
56. Hehl EM, Beck R, Luthard K, Guthoff R, Drewelow B. Improved penetration of aminoglycosides and fluorozuinolones into the aqueous humour of patients by means of Acuvue contact lenses. Eur. J. Clin. Pharmacol. 1999;55:317-323. (Pubitemid 29290925)
57. Haller I, Plempel M. Experimental in vitro and in vivo comparison of modern antimycotics. Curr. Med. Res. Opin. 1977;5:315-327. (Pubitemid 8300955)
58. Xu Y, Pang G, Gao C, Zhao D, Zhou L, Sun S, Wang B. In vitro comparison of the efficacies of natamycin and silver nitrate against ocular fungi. Antimicrob. Agents Chemother. 2009;53:1636-1638.